Status:
COMPLETED
Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar
Lead Sponsor:
Myat Htut Nyunt
Collaborating Sponsors:
Kangwon National University
Conditions:
Day-3 Positive of Parasitaemia
Prevalence of Drug Resistance Gene Mutation
Eligibility:
All Genders
2+ years
Brief Summary
* Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin resistance containment measures have been launched since 2009-2010. * It is important to monitor the spread and magnitu...
Eligibility Criteria
Inclusion
- confirmed uncomplicated falciparum malaria patients.
- age \>2 years
- box sex
- given informed consent
Exclusion
- severe malaria
- did not give informed consent
- others diseases
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT02198573
Start Date
July 1 2013
End Date
June 1 2014
Last Update
July 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Myat Phone Kyaw
Yangon, Yangon, Burma, 11191